NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues
J Hepatol. 2021 Feb;74(2):482-484.
doi: 10.1016/j.jhep.2020.09.006.
Epub 2020 Nov 19.
1 Department of Gastroenterology and Hepatology, Hamad Medical Corporation; Harvard T.H Chan School of Public Health, USA. Electronic address: [email protected].
2 Department of Gastroenterology and Hepatology, Hamad Medical Corporation; Harvard T.H Chan School of Public Health, USA.
3 Harvard T.H Chan School of Public Health, USA; Department of Infectious Disease, Communicable Disease Center, Doha, Qatar.
4 Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
5 Department of Gastroenterology and Hepatology, Hamad Medical Corporation.
6 Department of Infectious Disease, Communicable Disease Center, Doha, Qatar; Weill Cornell Medicine, Qatar (WCM-Q), Doha, Qatar.